Get the Stockscreener App
0.2108
13.14%
-0.0335
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.2108, with a volume of 4.26M.
It is down -13.14% in the last 24 hours and down -16.78% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.2443
Open:
$0.235
24h Volume:
4.26M
Relative Volume:
0.86
Market Cap:
$24.56M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.3243
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
+6.10%
1M Performance:
-16.78%
6M Performance:
-51.66%
1Y Performance:
-83.92%
1-Day Range:
$0.208
$0.242
1-Week Range:
$0.2001
$0.2453
52-Week Range:
$0.1996
$1.32
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.2102 | 28.55M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.70 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.45 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
721.77 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.03 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.37 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-25 | Initiated | Chardan Capital Markets | Buy |
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold - Investing.com
Reviva Pharmaceuticals Announces One-for-Twenty Reverse Stock Split - TipRanks
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 - Investing.com India
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
RVPH PE Ratio & Valuation, Is RVPH Overvalued - Intellectia AI
Risks Report: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant in a bullish channel2025 Price Momentum & Real-Time Volume Analysis - baoquankhu1.vn
Rate Hike: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant stock outperform in a bear marketShort Setup & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Levels Update: Will Reviva Pharmaceuticals Holdings Inc benefit from sector rotationJuly 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Sentiment: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflation2025 Stock Rankings & Smart Allocation Stock Tips - baoquankhu1.vn
Trade Report: Is Reviva Pharmaceuticals Holdings Inc exposed to currency risks2025 Price Momentum & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Guidance Update: Is Reviva Pharmaceuticals Holdings Inc forming a bullish divergenceJuly 2025 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn
Earnings Beat: Does Flywire Corporation stock have upside surprise potentialJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
What technical signals suggest for Reviva Pharmaceuticals Holdings Inc. stockJuly 2025 Market Mood & Real-Time Market Trend Scan - mfd.ru
Loss Report: Is ProShares Trust ProShares UltraPro MidCap400 stock forming a cup and handle2025 Volume Leaders & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Market Pulse: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investment2025 Top Gainers & Weekly High Return Forecasts - baoquankhu1.vn
Aug Spikes: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant in a bullish channelJuly 2025 Final Week & Weekly Breakout Watchlists - baoquankhu1.vn
Schizophrenia Market: Expanding Revenue Landscape to 2034 - openPR.com
Schizophrenia Market: Expanding Revenue Landscape to 2034 – DelveInsight | Teva Pharma, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharma, Reviva Pharma, Minerva Neurosciences - Barchart.com
Insider Sell: Is AMHPRG part of any ETF2025 Year in Review & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock outperform in a bear marketShort Setup & Smart Investment Allocation Tips - mfd.ru
Can Reviva Pharmaceuticals Holdings Inc. stock surprise with earnings upsideQuarterly Trade Summary & Free Risk Controlled Daily Trade Plans - mfd.ru
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock outperform tech sector in 2025Weekly Profit Report & Safe Entry Momentum Stock Tips - mfd.ru
Why is Reviva Pharmaceuticals Holdings Inc. stock going down2025 Market Trends & Low Risk Entry Point Guides - mfd.ru
How Reviva Pharmaceuticals Holdings Inc. stock compares to industry benchmarksJuly 2025 Decliners & High Accuracy Swing Entry Alerts - mfd.ru
What’s Reviva Pharmaceuticals Holdings Inc.’s historical returnWeekly Profit Summary & Growth Focused Stock Pick Reports - mfd.ru
Growth Value: Will Quetta Acquisition Corporation Equity Right outperform its industry peersFed Meeting & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant announce a stock splitJuly 2025 Price Swings & Weekly High Return Stock Opportunities - mfd.ru
How sensitive is Reviva Pharmaceuticals Holdings Inc. Equity Warrant to inflationWeekly Stock Summary & Proven Capital Preservation Tips - mfd.ru
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs in weak economy2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - mfd.ru
Published on: 2026-02-02 10:12:16 - baoquankhu1.vn
Rate Hike: What is the next catalyst for TLYSMarket Trend Summary & AI Driven Price Forecasts - baoquankhu1.vn
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant outperform during market ralliesWeekly Trend Recap & Daily Profit Maximizing Tips - mfd.ru
Retail Trends: What’s the fair value of OSIS stockMarket Sentiment Review & AI Driven Price Predictions - baoquankhu1.vn
Aug Selloffs: Can Reviva Pharmaceuticals Holdings Inc deliver alphaWeekly Trade Recap & Capital Protection Trading Alerts - baoquankhu1.vn
Guidance Update: Is TLRY a good stock for dollar cost averagingTrade Risk Summary & Target Return Focused Stock Picks - baoquankhu1.vn
RVPH Should I Buy - Intellectia AI
Published on: 2026-01-30 02:52:59 - baoquankhu1.vn
Breakout Watch: Does Franklin Wireless Corp have declining or rising EPSEarnings Overview Summary & Smart Investment Allocation Tips - baoquankhu1.vn
Market Leaders: Will DXPRC outperform tech stocks2025 Fundamental Recap & Low Volatility Stock Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Revolution Medicines (RVMD) and Bausch Health Companies (BHC) - The Globe and Mail
Gainers Report: What analysts say about Reviva Pharmaceuticals Holdings Inc stockInsider Buying & Low Volatility Stock Suggestions - baoquankhu1.vn
Chart Watch: Does BlackRock Science and Technology Trust have declining or rising EPSJuly 2025 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Aug Volume: Is ProShares Trust ProShares UltraShort Real Estate exposed to political risk2025 AllTime Highs & Long-Term Capital Growth Ideas - baoquankhu1.vn
Reviva Pharmaceuticals Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Moving Averages: Can IGNEP be the next market leaderWeekly Trend Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Aug EndMonth: What analysts say about Reviva Pharmaceuticals Holdings Inc stockEarnings Overview Summary & Low Risk Entry Point Tips - baoquankhu1.vn
Support Test: What makes Reviva Pharmaceuticals Holdings Inc stock attractive today2025 Market WrapUp & AI Driven Stock Movement Reports - baoquankhu1.vn
Trade Report: Is now the right time to enter Reviva Pharmaceuticals Holdings IncEarnings Recap Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
Technical Analysis: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant withstand a market correction2025 Dividend Review & Precise Swing Trade Alerts - baoquankhu1.vn
Market Outlook: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant stock showing strong momentumJuly 2025 Setups & Low Risk Investment Opportunities - baoquankhu1.vn
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.07%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):